Targeting IL-33/ST2 signaling: regulation of immune function and analgesia (2017)
- Authors:
- USP affiliated authors: ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, THIAGO MATTAR - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP
- Unidade: FMRP
- DOI: 10.1080/14728222.2017.1398734
- Subjects: DOR; INFLAMAÇÃO; DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO; NEURÔNIOS; ANALGESIA
- Keywords: Allodynia; MAPK; Glial cells; Hyperalgesia; Inflammatory pain; Neuropathy; Nociceptors; Pain therapy; Sensory neurons
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Expert Opinion on Therapeutic Targets
- ISSN: 1472-8222
- Volume/Número/Paginação/Ano: v. 21, n. 12, p. 1141-1152, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FATTORI, Victor et al. Targeting IL-33/ST2 signaling: regulation of immune function and analgesia. Expert Opinion on Therapeutic Targets, v. 21, n. 12, p. 1141-1152, 2017Tradução . . Disponível em: https://doi.org/10.1080/14728222.2017.1398734. Acesso em: 23 abr. 2024. -
APA
Fattori, V., Hohmann, M. S. N., Rossaneis, A. C., Manchope, M. F., Alves Filho, J. C. F., Cunha, T. M., et al. (2017). Targeting IL-33/ST2 signaling: regulation of immune function and analgesia. Expert Opinion on Therapeutic Targets, 21( 12), 1141-1152. doi:10.1080/14728222.2017.1398734 -
NLM
Fattori V, Hohmann MSN, Rossaneis AC, Manchope MF, Alves Filho JCF, Cunha TM, Cunha F de Q, Verri WA. Targeting IL-33/ST2 signaling: regulation of immune function and analgesia [Internet]. Expert Opinion on Therapeutic Targets. 2017 ; 21( 12): 1141-1152.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1080/14728222.2017.1398734 -
Vancouver
Fattori V, Hohmann MSN, Rossaneis AC, Manchope MF, Alves Filho JCF, Cunha TM, Cunha F de Q, Verri WA. Targeting IL-33/ST2 signaling: regulation of immune function and analgesia [Internet]. Expert Opinion on Therapeutic Targets. 2017 ; 21( 12): 1141-1152.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1080/14728222.2017.1398734 - Differential regulation of oxidative stress and cytokine production by endothelin ETA and ETB receptors in superoxide anion-induced inflammation and pain in mice
- Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice
- Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-kB activation
- 15d-PGJ2-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice
- The PI3Kγ/AKT signaling pathway mediates peripheral antinociceptive action of dipyrone
- Diosmin reduces chronic constriction injury-induced neuropathic pain in mice
- Probucol attenuates lipopolysaccharide-induced leukocyte recruitment and inflammatory hyperalgesia: effect on NF-кB activation and cytokine production
- Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects
- Pericytes modulate myelination in the central nervous system
- TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of TH17 cells by an AHR-independent mechanism
Informações sobre o DOI: 10.1080/14728222.2017.1398734 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
